Literature DB >> 29455229

Effect of Hospital Readmission Reduction on Patients at Low, Medium, and High Risk of Readmission in the Medicare Population.

Saul Blecker1,2,3, Jeph Herrin4,5, Ji Young Kwon6, Jacqueline N Grady6, Simon Jones7,3, Leora I Horwitz7,2,3.   

Abstract

BACKGROUND: Hospitalization and readmission rates have decreased in recent years, with the possible consequence that hospitals are increasingly filled with high-risk patients.
OBJECTIVE: We studied whether readmission reduction has affected the risk profile of hospitalized patients and whether readmission reduction was similarly realized among hospitalizations with low, medium, and high risk of readmissions.
DESIGN: Retrospective study of hospitalizations between January 2009 and June 2015. PATIENTS: Hospitalized fee-for-service Medicare beneficiaries, categorized into 1 of 5 specialty cohorts used for the publicly reported hospital-wide readmission measure. MEASUREMENTS: Each hospitalization was assigned a predicted risk of 30-day, unplanned readmission using a risk-adjusted model similar to publicly reported measures. Trends in monthly mean predicted risk for each cohort and trends in monthly observed to expected readmission for hospitalizations in the lowest 20%, middle 60%, and highest 20% of risk of readmission were assessed using time series models.
RESULTS: Of 47,288,961 hospitalizations, 16.2% (n = 7,642,161) were followed by an unplanned readmission within 30 days. We found that predicted risk of readmission increased by 0.24% (P = .03) and 0.13% (P = .004) per year for hospitalizations in the surgery/ gynecology and neurology cohorts, respectively. We found no significant increase in predicted risk for hospitalizations in the medicine (0.12%, P = .12), cardiovascular (0.32%, P = .07), or cardiorespiratory (0.03%, P = .55) cohorts. In each cohort, observed to expected readmission rates steadily declined, and at similar rates for patients at low, medium, and high risk of readmission.
CONCLUSIONS: Hospitals have been effective at reducing readmissions across a range of patient risk strata and clinical conditions. The risk of readmission for hospitalized patients has increased for 2 of 5 clinical cohorts.
© 2018 Society of Hospital Medicine

Entities:  

Mesh:

Year:  2018        PMID: 29455229      PMCID: PMC6063766          DOI: 10.12788/jhm.2936

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.960


  21 in total

1.  An automated model to identify heart failure patients at risk for 30-day readmission or death using electronic medical record data.

Authors:  Ruben Amarasingham; Billy J Moore; Ying P Tabak; Mark H Drazner; Christopher A Clark; Song Zhang; W Gary Reed; Timothy S Swanson; Ying Ma; Ethan A Halm
Journal:  Med Care       Date:  2010-11       Impact factor: 2.983

Review 2.  Risk prediction models for hospital readmission: a systematic review.

Authors:  Devan Kansagara; Honora Englander; Amanda Salanitro; David Kagen; Cecelia Theobald; Michele Freeman; Sunil Kripalani
Journal:  JAMA       Date:  2011-10-19       Impact factor: 56.272

Review 3.  Interventions to reduce 30-day rehospitalization: a systematic review.

Authors:  Luke O Hansen; Robert S Young; Keiki Hinami; Alicia Leung; Mark V Williams
Journal:  Ann Intern Med       Date:  2011-10-18       Impact factor: 25.391

4.  Readmissions, Observation, and the Hospital Readmissions Reduction Program.

Authors:  Rachael B Zuckerman; Steven H Sheingold; E John Orav; Joel Ruhter; Arnold M Epstein
Journal:  N Engl J Med       Date:  2016-02-24       Impact factor: 91.245

5.  Development and use of an administrative claims measure for profiling hospital-wide performance on 30-day unplanned readmission.

Authors:  Leora I Horwitz; Chohreh Partovian; Zhenqiu Lin; Jacqueline N Grady; Jeph Herrin; Mitchell Conover; Julia Montague; Chloe Dillaway; Kathleen Bartczak; Lisa G Suter; Joseph S Ross; Susannah M Bernheim; Harlan M Krumholz; Elizabeth E Drye
Journal:  Ann Intern Med       Date:  2014-11-18       Impact factor: 25.391

6.  Trends in hospitalizations and outcomes for acute cardiovascular disease and stroke, 1999-2011.

Authors:  Harlan M Krumholz; Sharon-Lise T Normand; Yun Wang
Journal:  Circulation       Date:  2014-08-18       Impact factor: 29.690

7.  Association between quality improvement for care transitions in communities and rehospitalizations among Medicare beneficiaries.

Authors:  Jane Brock; Jason Mitchell; Kimberly Irby; Beth Stevens; Traci Archibald; Alicia Goroski; Joanne Lynn
Journal:  JAMA       Date:  2013-01-23       Impact factor: 56.272

8.  Quasi-Experimental Evaluation of the Effectiveness of a Large-Scale Readmission Reduction Program.

Authors:  Grace Y Jenq; Margaret M Doyle; Beverly M Belton; Jeph Herrin; Leora I Horwitz
Journal:  JAMA Intern Med       Date:  2016-05-01       Impact factor: 21.873

9.  Variation in the risk of readmission among hospitals: the relative contribution of patient, hospital and inpatient provider characteristics.

Authors:  Siddhartha Singh; Yu-Li Lin; Yong-Fang Kuo; Ann B Nattinger; James S Goodwin
Journal:  J Gen Intern Med       Date:  2014-04       Impact factor: 5.128

10.  Implementation Science Workshop: primary care-based multidisciplinary readmission prevention program.

Authors:  Jamie Jurkiewicz Cavanaugh; Christine D Jones; Genevieve Embree; Katy Tsai; Thomas Miller; Betsy Bryant Shilliday; Brooke McGuirt; Robin Roche; Michael Pignone; Darren A DeWalt; Shana Ratner
Journal:  J Gen Intern Med       Date:  2014-05       Impact factor: 5.128

View more
  2 in total

1.  Seasonal Variation in Readmission Risk for Patients Hospitalized with Cardiopulmonary Conditions.

Authors:  Saul Blecker; Ji Young Kwon; Jeph Herrin; Jacqueline N Grady; Leora I Horwitz
Journal:  J Gen Intern Med       Date:  2018-05       Impact factor: 5.128

2.  Trends in Hospital Readmission of Medicare-Covered Patients With Heart Failure.

Authors:  Saul Blecker; Jeph Herrin; Li Li; Huihui Yu; Jacqueline N Grady; Leora I Horwitz
Journal:  J Am Coll Cardiol       Date:  2019-03-12       Impact factor: 24.094

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.